October 2016

PHOENIX, Aug. 18, 2016 (GLOBE NEWSWIRE) — Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced enrollment of the first patient in a Phase II clinical trial for the treatment of cocaine dependence using its pharmaceutical cannabidiol (CBD) product candidate. The study is being conducted by Dr. Didier Jutras-Aswad, MD, at the University of […]

by

Click here to receive MS news via e-mail AXIM Biotechnologies  announced it has secured financing from private sources to continue its testing of medical cannabinoid products as potential treatments for multiple indications, including pain and spasticity in people with multiple sclerosis (MS). Specifically, AXIM  is testing pharmaceutical delivery systems and active ingredients for its medical marijuana line. “This financing provides […]

by

Click here to receive MS news via e-mail AXIM Biotechnologies  announced it has secured financing from private sources to continue its testing of medical cannabinoid products as potential treatments for multiple indications, including pain and spasticity in people with multiple sclerosis (MS). Specifically, AXIM  is testing pharmaceutical delivery systems and active ingredients for its medical marijuana line. “This financing provides […]

by

CINCINNATI – A clinical trial to test whether medical marijuana can curb severe epileptic seizures has delivered “impressive” results, according to the study’s lead researcher at the University of Cincinnati. A trial of the drug Epidiolex – led by Dr. Michael Privitera of the Epilepsy Center at the UC Neuroscience Institute in Corryville – is […]

by

CINCINNATI – A clinical trial to test whether medical marijuana can curb severe epileptic seizures has delivered “impressive” results, according to the study’s lead researcher at the University of Cincinnati. A trial of the drug Epidiolex – led by Dr. Michael Privitera of the Epilepsy Center at the UC Neuroscience Institute in Corryville – is […]

by

DENVER, CO–(Marketwired – October 06, 2016) – O.penVAPE, the global leader in supercritical CO2 cannabis oil extraction, has revolutionized the industry by announcing the release of new O.penVAPE strain specific, THC-free CBD cartridges that will be distributed globally. These CBD products will appear in head shops, smoke shops and convenience stores throughout the… read more […]

by

OTTAWA, ONTARIO — (Marketwired) — 10/26/16 — Tetra Bio-Pharma Inc. (“Tetra Bio” or the “Company”) (CSE:TBP)(CSE:TBP.CN), through its subsidiary, Agro-Tek Inc. (“AGTK”), is pleased to announce that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived […]

by

Charlotte Figi had her first seizure when she was three months old. It began after a warm bath, a common precursor to the first seizures in Dravet Syndrome. Within a couple of years, she was experiencing over 300 spontaneous grand mal seizures a week. You may have heard of Charlotte’s story. She’s been featured on […]

by

SAN DIEGO, CA–(Marketwired – October 25, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today a partnership with CannaNative™, LLC (“CannaNative™”) to grow cannabis, produce the first-ever hemp oil products and develop economic opportunities on native lands in the United States. CannaNative™, the premiere Native American-owned company that uses cannabis to promote economic development… […]

by

CORAL SPRINGS, FL, Oct. 25, 2016 (Canada NewsWire via COMTEX) — The global marijuana and cannabis industries remain very active of late heading into the elections, as research and product development of new uses for varying strains and extracts of CBD, hemp cannabis propel the industry forward. Marijuana leaders active in the markets this week […]

by

Phase 1 clinical trial for ZYN001 is expected to begin in 1H17 Topline results for three Phase 2 clinical trials for ZYN002 are on track for 1H17 DEVON, Pa., Oct. 17, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today […]

by

Marijuana legalization will unleash misery on Arizona, according to a wave of television ads that started rolling out across the state last month. Replete with ominous music, the advertisements feature lawmakers and teachers who paint a bleak future for Arizona’s children if voters approve Proposition 205, a measure that would allow people aged 21 and […]

by

Charlotte Figi had her first seizure when she was three months old. It began after a warm bath, a common precursor to the first seizures in Dravet Syndrome. Within a couple of years, she was experiencing over 300 spontaneous grand mal seizures a week. You may have heard of Charlotte’s story. She’s been featured on […]

by

SEATTLE, WA — (Marketwired) — 10/20/16 — CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering new research, done in Mexico, that demonstrates the efficacy of Medical Marijuana, Inc.’s (OTC PINK: MJNA) RSHO-X™ in the treatment of children with refractory epilepsy. The […]

by

SAN DIEGO, CA–(Marketwired – October 20, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company HempMeds® Mexico, the first and only company dedicated to the cannabis industry with approval from COFEPRIS to legally import one of its products, will be present at the Senate of Mexico’s historic exhibition “Hemp for […]

by